01.25.24 -- Formycon Ranibizumab Biosimilar Achieved 38% Market Share In The U.S. In Dec 2023

This is the third article in a series of three articles. It continues the discussion of measurement system analysis using continuous gage R&D studies by sharing a generic example using Minitab. Study setup, the role of the study director, analysis, and case studies are examined.